Dr Mohamed Elrayess

Dr Mohamed Elrayess is the director of basic research at Qatar University’s Health Cluster. He has a PhD in cardiovascular genetics from University College London, United Kingdom, in 2003. He worked as a postdoctoral fellow at the Cardiovascular Medicine unit at University College London (2003-2004) and as a scientist at Eisai (2004-2012), a top international pharmaceutical company, where he developed skills in drug discovery and development, mainly focusing on stem cell therapy. He then spent the following 7 years (2012-2019) working as a senior scientist at Anti-Doping Lab Qatar, an international testing laboratory for doping abuse in elite athletes, using various OMICS approaches for the identification of novel biomarkers of insulin resistance and diabetes and investigating genetics and metabolomics of elite athletes. Dr Elrayess has joined Qatar University in 2019 as a research associate professor at the Biomedical Research Center where he leads the OMICS research group. His research is focused on investigating novel therapeutic targets in insulin resistance and diabetes as well as sports OMICS research. He has over 70 publications, supervised 3 PhD students and a number of MSc students and raised more than 3 million USD research funding.